Micah Benson

Micah Benson

Company: KSQ Therapeutics

Job title: Head of Immunology

Seminars:

TIL therapies: At the cellular level Q&A + Open Counsel 6:05 pm

Read more

day: Conference Day

CRISPR/Cas9-Engineered Tumor Infiltrating Lymphocyte (eTILTM) Therapies for Solid Tumors 5:15 pm

Systematic identification of genes restoring and amplifying T cell function in the tumor microenvironment Divulging updates on KSQ-001 and next generation TIL approaches Lessons learnt from the use of CRISPR/Cas9 for T cell rejuvenation and enhanced stability within the tumor microenvironmentRead more

day: Conference Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.